for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Perrigo Company PLC

PRGO.TA

Latest Trade

13,210.00ILa

Change

-50.00(-0.38%)

Volume

74,839

Today's Range

13,150.00

 - 

13,350.00

52 Week Range

13,150.00

 - 

20,990.00

As of on the New York Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
13,260.00
Open
13,320.00
Volume
74,839
3M AVG Volume
28.62
Today's High
13,350.00
Today's Low
13,150.00
52 Week High
20,990.00
52 Week Low
13,150.00
Shares Out (MIL)
133.57
Market Cap (MIL)
5,498.96
Forward P/E
14.61
Dividend (Yield %)
2.33

Next Event

Q1 2021 Perrigo Company PLC Earnings Release

Latest Developments

More

Perrigo Reports Q4 Adjusted Earnings Per Share $0.93 Excluding Items

Perrigo Announces Agreement To Sell Generic Rx Business For $1.55 Bln In Total Consideration

Perrigo Increases Quarterly Dividend By 7%

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Perrigo Company PLC

Perrigo Co. Plc engages in providing over-the-counter (OTC) self-care and wellness solutions. Its solutions enhance individual well-being by enabling consumers to proactively prevent or treat conditions that can be self-managed. The Company operates through three segments: Consumer Self-Care Americas, Consumer Self-Care International and Prescription Pharmaceuticals. The Consumer Self-Care Americas segment comprises the store brand consumer self-care business in the United States (U.S.), Mexico and Canada. The Consumer Self-Care International segment includes the branded consumer self-care business in Europe, along with generic consumer-focused businesses in the United Kingdom (U.K.) and Australia. The Prescription Pharmaceuticals segment commercializes and manufactures generic prescription products in the U.S. and diagnostic products in Israel.

Industry

Personal Services

Contact Info

The Sharp Building

Hogan Place, Dublin 2

D02 TY74

Ireland

+353.1.7094000

https://www.perrigo.com/

Executive Leadership

Murray S. Kessler

President, Chief Executive Officer, Director

Raymond P. Silcock

Chief Financial Officer, Executive Vice President

Robert Willis

Chief Human Resource Officer, Executive Vice President

Thomas M. Farrington

Executive Vice President, Chief Information Officer

James E. Dillard

Executive Vice President, Chief Scientific Officer

Key Stats

2.70 mean rating - 10 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2018

4.7K

2019

4.8K

2020

5.1K

2021(E)

4.2K
EPS (USD)

2018

4.550

2019

4.030

2020

4.160

2021(E)

2.819
Price To Earnings (TTM)
--
Price To Sales (TTM)
1.09
Price To Book (MRQ)
0.97
Price To Cash Flow (TTM)
24.75
Total Debt To Equity (MRQ)
63.06
LT Debt To Equity (MRQ)
62.39
Return on Investment (TTM)
-1.62
Return on Equity (TTM)
-1.43

Latest News

Latest News

BRIEF-Aspen's Infant Formula Unit Is Said To Draw Reckitt, Perrigo - Bloomberg

* ASPEN'S INFANT FORMULA UNIT IS SAID TO DRAW RECKITT, PERRIGO - BLOOMBERG, CITING SOURCES

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up